Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Symphony Clinical Research? Announces VP Appointment

Published: Thursday, February 21, 2013
Last Updated: Thursday, February 21, 2013
Bookmark and Share
Symphony Clinical Research? announced that industry veteran Kate Zarish has joined the company as its Vice President to lead and expand Global Clinical Operations.

Ms. Zarish is responsible for establishing and implementing the operational objectives and clinical processes employed by the global clinical team to deliver exceptional customer service with an unparalleled commitment to quality. She provides leadership to develop, grow and optimize the capabilities of Study Development, Study Management, Study Support and Document Management functions.

Ms. Zarish comes from Abbott Global Pharmaceutical Research & Development where she led an international team of study managers in the execution of clinical trial operations in multiple therapeutic areas. Kate was instrumental in the harmonization of global processes, tools and training programs for clinical study operations management, as well as standardizing study training for the monitoring staff. She maintains her certification as a Clinical Research Associate from ACRP.

“I am proud to be part of an organization that thinks about the patient first,” said Ms. Zarish. “The high standards we have established for in-home clinical services allows for trained health care professionals to ensure patient safety and to provide data with high integrity. It is the complete package for the patient, site and sponsor.”

Commenting on the new appointment, Nicki Norris, CEO states, “Kate’s role is critical in meeting the explosive demand for in-home clinical services. The pharmaceutical industry worldwide is beginning to realize the importance of reaching the intent-to-treat pool, accommodating debilitated patients, and retaining study participants all while completing trials on time. This is exactly what Symphony’s clinical services provide to our clients.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!